T. Koch et al., Perfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages, ANESTHESIOL, 94(1), 2001, pp. 101-109
Citations number
42
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Background: A number of studies have demonstrated the effectiveness of liqu
id ventilation with perfluorocarbons in improving pulmonary function in acu
te respiratory distress syndrome. Although it is known that perfluorocarbon
-associated gas exchange facilitates lung mechanics and oxygenation, the co
mplete mechanism by which perfluorocarbons exert their beneficial effects i
n acute lung injury still remains unclear. Possibly, an influence of perflu
orocarbons on proinflammatory and procoagulant features of monocytic cells
present in the alveolar space, such as alveolar macrophages (AMs), may be i
nvolved. Therefore, we examined in an in vitro model the effects of perfluo
rocarbon on both activated mononuclear blood cells (MBCs) and AMs by monito
ring the expression of interleukin (IL)-1 beta, tumor necrosis factor (TNF)
alpha, and tissue factor (TF).
Methods: Mononuclear blood cells, obtained from peripheral blood of healthy
volunteers, or AMs from diagnostic bronchoalveolar lavage were stimulated
by incubation with Lipopolysaccharide in the presence of different amounts
of perfluorohexane, which was devoid of cytotoxicity.
Results: Using both video-enhanced contrast and electron microscopy, the au
thors observed that perfluorohexane droplets were phagocytosed by activated
monocytes as web as by in vitro-cultured AMs within 1-3 h. After lipopolys
accharide stimulation of monocytes or AMs, we observed a down-regulation of
TF mRNA and a significant inhibition (P < 0.05) of cellular TF antigen by
perfluorohexane. In addition, the concentration of both IL-1<beta> and TNF
alpha in the supernatant of lipopolysaccharide-stimulated MBC was significa
ntly decreased (P < 0.01) by perfluorohexane compared with controls without
perfluorohexane. By preincubation of lipopolysaccharide-containing medium
with perfluorohexane, the authors could exclude that the inhibitory effect
of perfluorohexane was caused by binding or sequestering limited amounts of
Lipopolysaccharide.
Conclusion: Taken together, our results demonstrate an interference of perf
luorohexane with the expression of the procoagulant protein TF on monocytes
and AMs as well as with the release of proinflammatory cytokines by MBCs.
These effects may contribute to the protective role of liquid ventilation w
ith perfluorocarbons in injuries associated with local activation of inflam
matory processes.